Deconstruction of DNA methylation patterns during myogenesis reveals specific epigenetic events in the establishment of the skeletal muscle lineage

Stem Cells

Volumn 33, Issue 6, 2015, Pages 2025-2036

  Carrió, Elvira ^a,b   Díez Villanueva, Anna ^a,b   Lois, Sergi ^a   Mallona, Izaskun ^a,b   Cases, Ildefonso ^a   Forn, Marta ^a,c   Peinado, Miguel A ^a,b   Suelves, Mònica ^a,b  

^a FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

^b Germans Trias i Pujol Health Research Institute   (Spain)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cellular differentiation; DNA methylation; Myf5; Myogenesis; Stem cell; Super enhancers

Indexed keywords

GENOMIC DNA; MYOGENIC FACTOR 5; SPACER DNA; UPSTREAM STIMULATORY FACTOR 1; MUSCLE PROTEIN;

AMPLICON; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SPECIFICITY; CHROMATIN; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; ENHANCER REGION; EPIGENETICS; GENE EXPRESSION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE STEM CELL; MYOBLAST; MYOTUBE; NEXT GENERATION SEQUENCING; NONHUMAN; PROTEIN BINDING; SKELETAL MUSCLE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN EMBRYONIC STEM CELL; METABOLISM;

CELL DIFFERENTIATION; CELL LINEAGE; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMAN EMBRYONIC STEM CELLS; HUMANS; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLE, SKELETAL;

EID: 84929836984     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1998     Document Type: Article

References (90)

1. Reik W,. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447: 425-432.
2. Smith ZD, Meissner A,. DNA methylation: Roles in mammalian development. Nat Rev Genet 2013; 14: 204-220.
3. Jones PA,. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484-492.
4. Rakyan VK, Down TA, Thorne NP, et al., An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 2008; 18: 1518-1529.
5. Straussman R, Nejman D, Roberts D, et al., Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol 2009; 16: 564-571.
6. Fernandez AF, Assenov Y, Martin-Subero JI, et al., A DNA methylation fingerprint of 1628 human samples. Genome Res 2012; 22: 407-419.
7. Nagae G, Isagawa T, Shiraki N, et al., Tissue-specific demethylation in CpG-poor promoters during cellular differentiation. Hum Mol Genet 2011; 20: 2710-2721.
8. Liang P, Song F, Ghosh S, et al., Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development. BMC Genomics 2011; 12: 231.
9. Lister R, Pelizzola M, Dowen RH, et al., Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462: 315-322.
10. Ji H, Ehrlich LI, Seita J, et al., Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010; 467: 338-342.
11. Laurent L, Wong E, Li G, et al., Dynamic changes in the human methylome during differentiation. Genome Res 2010; 20: 320-331.
12. Stadler MB, Murr R, Burger L, et al., DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 2011; 480: 490-495.
13. Isagawa T, Nagae G, Shiraki N, et al., DNA methylation profiling of embryonic stem cell differentiation into the three germ layers. PLoS One 2011; 6: e26052.
14. Xie W, Schultz MD, Lister R, et al., Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 2013; 153: 1134-1148.
15. Gifford CA, Ziller MJ, Gu H, et al., Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell 2013; 153: 1149-1163.
16. Buckingham M, Rigby PW,. Gene regulatory networks and transcriptional mechanisms that control myogenesis. Dev Cell 2014: 2225-2038.
17. Moncaut N, Rigby PW, Carvajal JJ,. Dial M(RF) for myogenesis. FEBS J 2013; 280: 3980-3990.
18. Carvajal JJ, Cox D, Summerbell D, et al., A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. Development 2001; 128: 1857-1868.
19. Hadchouel J, Carvajal JJ, Daubas P, et al., Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus. Development 2003; 130: 3415-3426.
20. Chang TH, Primig M, Hadchouel J, et al., An enhancer directs differential expression of the linked Mrf4 and Myf5 myogenic regulatory genes in the mouse. Dev Biol 2004; 269: 595-608.
21. Zammit PS, Golding JP, Nagata Y, et al., Muscle satellite cells adopt divergent fates: A mechanism for self-renewal? J Cell Biol 2004; 166: 347-357.
22. Carvajal JJ, Keith A, Rigby PW,. Global transcriptional regulation of the locus encoding the skeletal muscle determination genes Mrf4 and Myf5. Genes Dev 2008; 22: 265-276.
23. Ribas R, Moncaut N, Siligan C, et al., Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments. Dev Biol 2011; 355: 372-380.
24. Whyte WA, Orlando DA, Hnisz D, et al., Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013; 153: 307-319.
25. Hnisz D, Abraham BJ, Lee TI, et al., Super-enhancers in the control of cell identity and disease. Cell 2013; 155: 934-947.
26. Suelves M, Vidal B, Serrano AL, et al., uPA deficiency exacerbates muscular dystrophy in MDX mice. J Cell Biol 2007; 178: 1039-1051.
27. Frigola J, Ribas M, Risques RA, et al., Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res 2002; 30: e28.
28. Clark SJ, Millar DS, Molloy P,. Bisulfite methylation analysis of tumor suppressor genes in prostate cancer from fresh and archival tissue samples. Methods Mol Med 2003; 81: 219-240.
29. Hume MA, Barrera LA, Gisselbrecht SS, et al., UniPROBE, update 2015: New tools and content for the online database of protein-binding microarray data on protein-DNA interactions. Nucleic Acids Res 2014; 43: D117-D122.
30. Jolma A, Yan J, Whitington T, et al., DNA-binding specificities of human transcription factors. Cell 2013: 2327-2039.
31. Bryne JC, Valen E, Tang MH, et al., JASPAR, the open access database of transcription factor-binding profiles: New content and tools in the 2008 update. Nucleic Acids Res 2008;2036 2102-2006.
32. Lam EW, Brosens JJ, Gomes AR, et al., Forkhead box proteins: Ttuning forks for transcriptional harmony. Nat Rev Cancer 2013: 2482-2095.
33. Butler JE, Kadonaga JT,. The RNA polymerase II core promoter: A key component in the regulation of gene expression. Genes Dev 2002; 16: 2583-2592.
34. Rettino A, Rafanelli F, Genovese G, et al., Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter. Am J Physiol Cell Physiol 2009; 297: C1113-23.
35. Parakati R, DiMario JX,. Sp1- and Sp3-mediated transcriptional regulation of the fibroblast growth factor receptor 1 gene in chicken skeletal muscle cells. J Biol Chem 2001: 9278-2085.
36. Zelko IN, Mueller MR, Folz RJ,. CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression. Free Radic Biol Med 2010; 895-904.
37. Dunham I,. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 2057-2074.
38. Blum R, Vethantham V, Bowman C, et al., Genome-wide identification of enhancers in skeletal muscle: The role of MyoD1. Genes Dev 2012:2012 Dec 2015;2026:2763-2079.
39. Kelly CE, Thymiakou E, Dixon JE, et al., Rnf165/Ark2C enhances BMP-Smad signaling to mediate motor axon extension. PLoS Biol 2013; e1001538.
40. Tessema M, Yingling CM, Grimes MJ, et al., Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers. PLoS One 2012; 7: e34850.
41. Xu K, Chong DC, Rankin SA, et al., Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation. Dev Biol 2009; 329: 269-279.
42. Huang Y, Das AK, Yang QY, et al., Zfp423 promotes adipogenic differentiation of bovine stromal vascular cells. PLoS One 2012; 7: e47496.
43. Zhan M, Riordon DR, Yan B, et al., The B-MYB transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells. PLoS One 2012; 7: e42350.
44. Tian L, Wu X, Lin Y, et al., Characterization and potential function of a novel pre-implantation embryo-specific RING finger protein: TRIML1. Mol Reprod Dev. 2009; 2076: 2656-2064.
45. Tung PY, Varlakhanova NV, Knoepfler PS,. Identification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenes. Stem Cells 2013: 2330-2042.
46. Chen C, Ridzon D, Lee CT, et al., Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets. Mamm Genome 2007; 2018: 2316-2027.
47. Suh MR, Lee Y, Kim JY, et al., Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004; 270: 488-498.
48. Card DA, Hebbar PB, Li L, et al., Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008; 28: 6426-6438.
49. Subramanyam D, Lamouille S, Judson RL, et al., Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011; 29: 443-448.
50. Anokye-Danso F, Trivedi Chinmay M, Juhr D, et al., Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8: 376-388.
51. Loh YH, Wu Q, Chew JL, et al., The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006; 2038: 2431-2040.
52. Messina G, Biressi S, Monteverde S, et al., Nfix regulates fetal-specific transcription in developing skeletal muscle. Cell 2010; 2554-2066.
53. Nebl G, Cato AC,. NFI/X proteins: A class of NFI family of transcription factors with positive and negative regulatory domains. Cell Mol Biol Res 1995; 41: 85-95.
54. Ott MO, Bober E, Lyons G, et al., Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo. Development 1991; 111: 1097-1107.
55. Arnold HH, Braun T,. Genetics of muscle determination and development. Curr Top Dev Biol 2000; 48: 129-164.
56. Daubas P, Buckingham ME,. Direct molecular regulation of the myogenic determination gene Myf5 by Pax3, with modulation by Six1/4 factors, is exemplified by the -111 kb-Myf5 enhancer. Dev Biol 2013; 376: 236-244.
57. Summerbell D, Ashby PR, Coutelle O, et al., The expression of Myf5 in the developing mouse embryo is controlled by discrete and dispersed enhancers specific for particular populations of skeletal muscle precursors. Development 2000; 127: 3745-3757.
58. Teboul L, Hadchouel J, Daubas P, et al., The early epaxial enhancer is essential for the initial expression of the skeletal muscle determination gene Myf5 but not for subsequent, multiple phases of somitic myogenesis. Development 2002; 129: 4571-4580.
59. Sato T, Rocancourt D, Marques L, et al., A Pax3/Dmrt2/Myf5 regulatory cascade functions at the onset of myogenesis. PLoS Genet 2010; 6: e1000897.
60. Carvajal JJ, Rigby PW,. Regulation of gene expression in vertebrate skeletal muscle. Exp Cell Res 2010; 316: 3014-3018.
61. Bajard L, Relaix F, Lagha M, et al., A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev 2006; 20: 2450-2464.
62. Berdasco M, Esteller M,. DNA methylation in stem cell renewal and multipotency. Stem Cell Res Ther 2011; 2: 42.
63. Wang YX, Rudnicki MA,. Satellite cells, the engines of muscle repair. Nat Rev Mol Cell Biol 2012; 13: 127-133.
64. Mohn F, Weber M, Rebhan M, et al., Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 2008; 30: 755-766.
65. Kim H, Jang MJ, Kang MJ, et al., Epigenetic signatures and temporal expression of lineage-specific genes in hESCs during differentiation to hepatocytes in vitro. Hum Mol Genet 2011; 20: 401-412.
66. Meissner A, Mikkelsen TS, Gu H, et al., Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454: 766-771.
67. Bock C, Beerman I, Lien WH, et al., DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. Mol Cell 2012; 47: 633-647.
68. Brunner AL, Johnson DS, Kim SW, et al., Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Research 2009; 19: 1044-1056.
69. Barrera V, Peinado MA,. Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale. Nucleic Acids Res 2012; 40: 11490-11498.
70. Smiraglia DJ, Rush LJ, Fruhwald MC, et al., Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001; 10: 1413-1419.
71. Shen Y, Matsuno Y, Fouse SD, et al., X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc Natl Acad Sci 2008; 105: 4709-4714.
72. Illingworth RS, Bird AP,. CpG islands-'A rough guide'. FEBS Lett 2009; 583: 1713-1720.
73. Shukla S, Kavak E, Gregory M, et al., CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011; 2479: 2074-2019.
74. Sati S, Tanwar VS, Kumar KA, et al., High resolution methylome map of rat indicates role of intragenic DNA methylation in identification of coding region. PLoS ONE 2012; 7: e31621.
75. Gelfman S, Cohen N, Yearim A, et al., DNA-methylation effect on cotranscriptional splicing is dependent on GC architecture of the exon-intron structure. Genome Res 2013; 23: 789-799.
76. Jabbari K, Bernardi G,. CpG doublets, CpG islands and Alu repeats in long human DNA sequences from different isochore families. Gene 1998; 224: 123-127.
77. Xie M, Hong C, Zhang B, et al., DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape. Nat Genet 2013; 45: 836-841.
78. Wang J, Gong C, Maquat LE,. Control of myogenesis by rodent SINE-containing lncRNAs. Genes Dev 2013; 27: 793-804.
79. Tsumagari K, Baribault C, Terragni J, et al., Early de novo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics 2013; 8: 317-332.
80. Miyata K, Miyata T, Nakabayashi K, et al., DNA methylation analysis of human myoblasts during in vitro myogenic differentiation: De novo methylation of promoters of muscle-related genes and its involvement in transcriptional down-regulation. Hum Mol Genet 2015; 24: 410-423.
81. Hon GC, Rajagopal N, Shen Y, et al., Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet 2013; 45: 1198-1206.
82. Buck-Koehntop BA, Defossez PA,. On how mammalian transcription factors recognize methylated DNA. Epigenetics 2013; 8: 131-137.
83. Deng C, Li Y, Liang S, et al., USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription. PLoS Genet 2013; 9: e1003524.
84. Huang S, Li X, Yusufzai TM, et al., USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. Mol Cell Biol 2007; 2027: 7991-8002.
85. Aoki M, Terada T, Kajiwara M, et al., Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation. Am J Physiol Renal Physiol 2008; 295: F165-F170.
86. Berger A, Cultaro CM, Segal S, et al., The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF), a basic helix-loop-helix-zipper protein. Biochim Biophys Acta 1998; 16: 225-236.
87. Cheung E, Mayr P, Coda-Zabetta F, et al., DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation. Biochem J 1999; 1: 145-152.
88. Galibert MD, Carreira S, Goding CR,. The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced tyrosinase expression. EMBO J 2001; 20: 5022-5031.
89. Xiao Q, Kenessey A, Ojamaa K,. Role of USF1 phosphorylation on cardiac alpha-myosin heavy chain promoter activity. Am J Physiol Heart Circ Physiol 2002; 283: H213-H219.
90. Corre S, Galibert MD,. USF as a key regulatory element of gene expression. Med Sci 2006; 22: 62-67.